Aug 30 (Reuters) - VBI Vaccines Inc VBIV.O
* VBI Vaccines announces FDA acceptance of investigational new drug application for SCI-B-VAC(R) phase 3 clinical program
* VBI Vaccines Inc - expects to initiate enrollment in a phase 3 clinical program later in second half of 2017 in U.S., Europe and Canada